Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: A prospective, open pilot study

Journal of Clinical Psychiatry

Volumn 72, Issue 9, 2011, Pages 1263-1269

  Wall, Christopher A ^a   Croarkin, Paul E ^b   Sim, Leslie A ^a   Husain, Mustafa M ^b   Janicak, Philip G ^c   Kozel, F Andrew ^b   Emslie, Graham J ^b   Dowd, Sheila M ^c   Sampson, Shirlene M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; CHILD PSYCHIATRY; CHILDREN DEPRESSION RATING SCALE REVISED; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG TREATMENT FAILURE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; PATIENT SAFETY; PHYSICAL TOLERANCE; PILOT STUDY; PRACTICE GUIDELINE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; STIMULUS RESPONSE; SUICIDAL IDEATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 80053020524     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07003     Document Type: Article

References (25)

1. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64(10):1132-1143. doi:10.101/archpsyc.64.10.132 PubMed
2. March J, Silva S, Petrycki S, et al Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820. doi:10.101/jama.292.7.807 PubMed (Pubitemid 39079667)
3. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913. doi:10.101/jama.29.8.901 PubMed (Pubitemid 351397065)
4. Walkup JT. Treatment of depressed adolescents. Am J Psychiatry. 2010;167(7):734-737. doi:10.176/api.ajp.2010.104056 PubMed
5. Croarkin PE, Wall CA, McClintock SM, et al. The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression. J ECT. 2010;26(4):323-329. doi:10.1097/YCT. 0b013e3181d17eb PubMed
6. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516. doi:10.101/ archgenpsychiatry.2010.46 PubMed
7. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216. doi:10.1016/j.biopsych.207.01.018 PubMed (Pubitemid 350060890)
8. Walter G, Tormos JM, Israel JA, et al. Transcranial magnetic stimulation in young persons: a review of known cases. J Child Adolesc Psychopharmacol. 2001;11(1):69-75. doi:10.1089/10454601750143483 PubMed (Pubitemid 32295185)
9. Loo C, McFarquhar T, Walter G. Transcranial magnetic stimulation in adolescent depression. Australas Psychiatry. 2006;14(1):81-85. PubMed
10. Bloch Y, Grisaru N, Harel EV, et al. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT. 2008;24(2):156-159. doi:10.1097/YCT.0b013e318156a49 PubMed
11. D'Agati D, Bloch Y, Levkovitz Y, et al. rTMS for adolescents: safety and efficacy considerations. Psychiatry Res. 2010;177(3):280-285. doi:10.1016/j.psychres.2010.03.04 PubMed
12. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1-16. doi:10.1016/S0168- 597(97)096-8 PubMed
13. Janicak PG, O'Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69(2):222-232. doi:10.408/JCP.v69n0208 PubMed (Pubitemid 351469265)
14. Rossi S, Hallett M, Rossini PM, et al Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120(12):2008-2039. doi:10.1016/j.clinph.209.08.016 PubMed
15. Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988. doi:10.1097/04583-197070-021 PubMed (Pubitemid 27272932)
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press; 2000.
17. Poznanski EO, Freeman LN, Mokros HB. Children's Depression Rating Scale-Revised (September 1984). Psychopharmacol Bull. 1985;21:979-989. (Pubitemid 16177295)
18. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17. PubMed
19. George MS, Wassermann EM, Williams WA, et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport. 1995;6(14):1853-1856. doi:10.1097/01756-1951020-08 PubMed
20. Talley JL. Children's Auditory and Verbal Learning Test-2 (CAVLT-2). Odessa, FL: Psychological Assessment Resources; 1993.
21. Kopelman MD, Wilson BA, Baddeley AD. The Autobiographical Memory Interview: a new assessment of autobiographical and personal semantic memory in amnesic patients. J Clin Exp Neuropsychol. 1989;11(5):724-744. doi:10.1080/016863890840928 PubMed
22. Delis DC, Kramer JH, Kaplan E, et al. Reliability and validity of the Delis-Kaplan Executive Function System: an update. J Int Neuropsychol Soc. 2004;10(2):301-303. doi:10.1017/S13561704102191 PubMed (Pubitemid 38418188)
23. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. doi:10.1016/S06-323(02)0186-8 PubMed (Pubitemid 37289444)
24. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976:218-222.
25. Posner K, Brent D, Lucas C, et al. Columbia-Suicide Severity Rating Scale (C-SSRS). New York, NY: Columbia University; 2008.